Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282225 · ClinicalTrials.gov registry record · NA
Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care
A NA study of Suicide and Suicidal Ideation, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT05282225: Active NA study of Suicide and Suicidal Ideation, sponsored by University of Michigan.
NCT05282225 is a NA study of Suicide and Suicidal Ideation that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 300 participants, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05282225, a NA study of Suicide and Suicidal Ideation, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is being completed to examine different combinations of technology-augmented strategies to identify an effective Adaptive intervention (AI) addressing post-discharge suicide risk with high implementation potential.
Primary Outcome
This is a semi-structured interview and will be used to assess suicidal behavior (actual, interrupted, aborted suicide attempts).
Conditions Studied
Interventions
- BEHAVIORAL MI- Safety Plan
- BEHAVIORAL Texts messages
- BEHAVIORAL Monitoring
- BEHAVIORAL Portal follow-up
- BEHAVIORAL Booster call
Study Locations (3)
Michigan
- University of Michigan's (Child and Adolescent Psychiatric Inpatient Program) - Ann Arbor
- Henry Ford Health System (Kingwood Hospital) - Detroit
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05282225 still lists
NCT05282225 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Suicide appearing as the primary indexed condition, and to 5 interventions - of which MI- Safety Plan is the first listed.
NCT05282225 reports a single indexed study location in Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT05282225 about?
NCT05282225 is a clinical study titled "Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care". This study is being completed to examine different combinations of technology-augmented strategies to identify an effective Adaptive intervention (AI) addressing post-discharge suicide risk with high implementation potential.
What is the current status of trial NCT05282225?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-11-07. Estimated completion is 2026-06-30.
What conditions does trial NCT05282225 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide, Attempted, Self Harm.
What interventions are being tested in trial NCT05282225?
The interventions under investigation include: MI- Safety Plan (BEHAVIORAL), Texts messages (BEHAVIORAL), Monitoring (BEHAVIORAL), Portal follow-up (BEHAVIORAL), Booster call (BEHAVIORAL).
Who is sponsoring clinical trial NCT05282225?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282225 being conducted?
This trial has 3 study locations across Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05282225's enrollment target sits among peer trials
300 25th of 92 higher than 67 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI